CIK 0001720893 · Non-accelerated filer<br>Smaller reporting company
BioXcel Therapeutics, Inc.
Sign in to watch- Ticker
- BTAIQ
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821386754
- Phone
- 203-643-8060
- Business address
- 555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
- 4 Open-market sale Chief Scientific Officer sold 985 shares at $19.69 ($19,396)
- 4 Option exercise CEO and President acquired 10,437 shares (option exercise)
- 4 Open-market sale Chief Medical Officer sold 845 shares at $19.70 ($16,642)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale See Remarks sold 950 shares at $19.63 ($18,644)
- 8-K Event Other events
- 10-K Report Annual Report
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Results of operations
- 8-K Event Other events
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Other events
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
Page 19 of 34 · 672 filings